Zobrazeno 1 - 8
of 8
pro vyhledávání: '"MP Quesada Sanz"'
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Ustekinumab is a monoclonal antibody that inhibits the bioactivity of IL-12 and IL-23 causing a decrease in inflammatory markers in Crohn’s disease (CD), used in patients in whom conventional treatment or anti-TNF is insuf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::869ca1447220a713e5dff69a146655bd
https://doi.org/10.1136/ejhpharm-2020-eahpconf.377
https://doi.org/10.1136/ejhpharm-2020-eahpconf.377
Autor:
J Romero Puerto, MP Quesada Sanz, JM Rodriguez García, E Márquez Fernández, P Villanueva Jimenez
Publikováno v:
Clinical pharmacy.
Background Nivolumab is a human monoclonal antibody against the programmed death-1 receptor (PD-1) that prevents inactivation of T lymphocytes. Purpose To assess the efficacy and safety of nivolumab in squamous non-small cell lung cancer (NSCLC). Mat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0afbf793ca43e4994637a054903a50f
https://doi.org/10.1136/ejhpharm-2017-000640.73
https://doi.org/10.1136/ejhpharm-2017-000640.73
Publikováno v:
European Journal of Hospital Pharmacy. 22:A138.4-A139
Background Pure red cell aplasia is a severe, non-regenerative form of anaemia, with selective erythroid aplasia of the bone marrow. Although there are congenital forms, most cases are adquired by toxic, radiation or drugs and 50% are idiopathic. Pur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4df5448d0452e7d0d2950b0e73d1d56f
https://doi.org/10.1136/ejhpharm-2015-000639.333
https://doi.org/10.1136/ejhpharm-2015-000639.333
DI-043 Appropriateness of telaprevir treatment in patients with chronic hepatitis C virus genotype 1
Publikováno v:
European Journal of Hospital Pharmacy. 21:A87.2-A88
Background The length of treatment with triple therapy against hepatitis C virus genotype 1 (HCV-1), which comprises telaprevir, ribavirin and peginterferon α-2b, is variable, depending on the patient to be treated. Purpose To evaluate the use and e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad1c1470888954f79867af707ba0f207
https://doi.org/10.1136/ejhpharm-2013-000436.214
https://doi.org/10.1136/ejhpharm-2013-000436.214
Publikováno v:
European Journal of Hospital Pharmacy. 20:A106.2-A106
Background The addition of telaprevir to standard treatment considerably improves response rates and allows the duration of treatment to be reduced in a significant number of patients. Purpose To assess the efficacy and safety of telaprevir in combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5446c655c6ade8319b3919aa5083d39d
https://doi.org/10.1136/ejhpharm-2013-000276.296
https://doi.org/10.1136/ejhpharm-2013-000276.296
Autor:
MP Quesada Sanz, JJ Ramos Báez, M. Gallego Galisteo, F. Téllez Pérez, J.C. Roldán Morales, B Marmesat Rodas
Publikováno v:
European Journal of Hospital Pharmacy. 19:121.3-122
Background Reconciliation of discrepancies in the patient9s treatment may improve the quality of healthcare in a population susceptible to drug errors. Purpose To analyse differences detected in home treatment after hospital discharge for polymedicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ba481e5369effcd03a1a6a2d607656d
https://doi.org/10.1136/ejhpharm-2012-000074.97
https://doi.org/10.1136/ejhpharm-2012-000074.97
Publikováno v:
European Journal of Hospital Pharmacy. 19:174.3-175
Background The use of calcium and magnesium reduces both the incidence and time of development of peripheral sensory neurotoxicity, oxaliplatin-limiting toxicity. Purpose To determine the effectiveness of calcium gluconate and magnesium sulphate in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33a9ebf1c6a480cfc4a1bf17cfa75396
https://doi.org/10.1136/ejhpharm-2012-000074.236
https://doi.org/10.1136/ejhpharm-2012-000074.236
Autor:
Asensi Díez R; Servicio de Farmacia, Hospital Regional Universitario Carlos Haya, Avenida de Carlos Haya s/n, 29010 Málaga. rocioasensi-diez@hotmail.com, Quesada Sanz MP, Valverde Molina E, de Ramón Garrido E, Gómez Maldonado J, Muñoz Castillo I
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2006 May-Jun; Vol. 30 (3), pp. 142-8.